N-Nonyldeoxynojirimycin (NN-DNJ) is a potent inhibitor of alpha-glucosidase and alpha-1,6-glucosidase (IC50s, 0.42, 8.4 μM, respectively), inhibits glycogen breakdown.
N-Nonyldeoxynojirimycin is a potent iminosugar derivative known for its role as a glycosidase inhibitor, particularly targeting alpha-glucosidases. Structurally, it is characterized by a deoxynojirimycin core substituted with a nonyl alkyl chain, which enhances its lipophilicity and membrane permeability. This compound has garnered significant attention in biochemical and glycobiology research due to its ability to modulate carbohydrate-processing enzymes. Its unique inhibitory profile makes it a valuable tool for probing glycosidase function and for developing mechanistic insights into carbohydrate metabolism and glycan processing in various biological systems.
Enzyme inhibition studies: N-Nonyldeoxynojirimycin is widely utilized in research focused on the inhibition of alpha-glucosidases and related glycosidases. By serving as a competitive inhibitor, it enables detailed kinetic analyses of enzyme activity and specificity, facilitating the elucidation of glycosidase catalytic mechanisms. Researchers employ this compound to dissect the roles of specific glycosidases in metabolic pathways, supporting the identification of critical enzymatic steps involved in glycogenolysis and glycoprotein maturation.
Glycobiology research: The compound's capacity to interfere with glycan processing has established its utility in the study of glycoprotein biosynthesis, folding, and quality control within the endoplasmic reticulum. By modulating the activity of glucosidases involved in N-linked glycan trimming, N-Nonyldeoxynojirimycin allows investigators to monitor the consequences of altered glycosylation patterns on protein stability, trafficking, and function. This has proven particularly valuable in uncovering the molecular underpinnings of glycoprotein-associated disorders and in advancing the understanding of cellular glycome dynamics.
Cell-based assay development: Due to its cell-permeable nature, N-Nonyldeoxynojirimycin is frequently implemented in the design and optimization of cell-based assays that require precise modulation of intracellular glycosidase activity. Its use enables researchers to create model systems for studying the effects of glycosidase inhibition on cellular physiology, signal transduction, and metabolic flux. These applications are pivotal for screening enzyme inhibitors, validating molecular targets, and characterizing the cellular consequences of glycan modification.
Metabolic pathway analysis: The compound's inhibitory action on carbohydrate-processing enzymes makes it a powerful tool for metabolic pathway mapping. By selectively blocking specific steps in oligosaccharide breakdown or glycoprotein processing, N-Nonyldeoxynojirimycin facilitates the accumulation of pathway intermediates, which can then be analyzed using advanced analytical techniques. This approach aids in the identification of novel metabolic routes, regulatory checkpoints, and potential intervention points within complex carbohydrate networks.
Analytical method development: Researchers leverage the distinctive properties of N-Nonyldeoxynojirimycin to refine analytical protocols for glycosidase activity measurement and glycan profiling. Its inclusion in assay systems enhances the sensitivity and specificity of detection methods, supporting high-throughput screening, inhibitor profiling, and detailed enzymatic characterization. The compound's well-defined inhibitory profile provides a robust reference for benchmarking new analytical techniques and validating assay performance in both academic and industrial research settings.
1. TMEM16F and dynamins control expansive plasma membrane reservoirs
3. An Open-label, Single-center, Safety and Efficacy Study of Eyelash Polygrowth Factor Serum
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More